More ‘biosimilar’ medicines should be brought to market in the EU because of a regulatory policy shift on the need to carry ...

The APPA, if passed into law, puts an upper limit of 20 patents, but only of certain types of patents (see below), that can be asserted in a BPCIA litigation (the APPA does not affect ANDA litigations ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...

"I wanted to create something that not only alleviates physical pain but also brings a sense of comfort and joy to children during what can be a distressing time," said an inventor, from Gallatin, ...

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

Biosimilars and biobetters present a lucrative ... His responsibilities at Roche involved the design and implementation of development strategies for numerous novel chemical entities (NCE ...

"I wanted to create a fashionable, hygienic, and comfortable alternative to positioning the posts of earrings through a hole within the ear lobe," said an inventor, from Chicago, Ill., "so I invented ...

Nandita Vijayasimha, Bengaluru Thursday, April 3, 2025, 08:00 Hrs [IST] ...

Adeel Hasan, Country Manager - Philippines, Glenmark Philippines Inc. said, "Addressing child malnutrition and maternal ...

“Automation has already been heavily utilized in many aspects of mAb manufacturing, such as process control, monitoring, and testing. Continued investment in automation will further reduce cost by ...